Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 10.20 Britannia Life Science Center Lease, Dated As of April 28, 2016, by and Among Blade Therapeutics, Inc. and Bayside Acquisition, LLC
- 10.21 First Amendment to Lease, Dated As of October 15, 2021, by and Among Blade Therapeutics, Inc. and Bayside Acquisition, LLC
- 10.22 Sublease Agreement, Dated As of October 1, 2019, by and Among Blade Therapeutics, Inc. and Molecular Transport Inc.
- 21.1 List of Subsidiaries of the Registrant
- 23.1 Consent of Marcum LLP
- 23.2 Consent of Ernst and Young LLP, Independent Registered Accounting Firm for Blade Therapeutics, Inc
- 99.1 Form of Proxy Card for Extraordinary General Meeting
- 99.9 Consent of Vantage Point Advisors, Inc.
- EX-FILING FEES Filing Fee Table
- Download Excel data file
- View Excel data file
Associated filings
- 17 Jun 22 RW Registration withdrawal request
- 23 May 22 424B3 Prospectus supplement
- 10 May 22 EFFECT Notice of effectiveness
- 9 May 22 424B3 Prospectus supplement
- 9 May 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 3 May 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 15 Apr 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 1 Apr 22 S-4/A Registration of securities issued in business combination transactions (amended)
-
15 Mar 22 S-4 Registration of securities issued in business combination transactions
BIOT similar filings
- 3 May 22 Registration of securities issued in business combination transactions (amended)
- 15 Apr 22 Registration of securities issued in business combination transactions (amended)
- 1 Apr 22 Registration of securities issued in business combination transactions (amended)
- 15 Mar 22 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the inclusion in this Registration Statement of Biotech Acquisition Company on Form S-4 of our report dated March 7, 2022, with respect to our audits of the consolidated financial statements of Biotech Acquisition Company as of December 31, 2021 and 2020 and for the year ended December 31, 2021 and for the period from September 3, 2020 (inception) through December 31, 2020, which report appears in the proxy statement/prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such proxy statement/prospectus.
/s/ Marcum llp
Marcum llp
Philadelphia, Pennsylvania
March 15, 2022